Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year-Reference-Cited by-同舟云学术

Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year

Published:2013-02-09 Issue:5 Volume:7 Page:854-862
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:

Author:

Bennett Alayne L.¹,Smith David W.,Cummins Martin J.²,Jacoby Peter A.³,Cummins Joseph M.²,Beilharz Manfred W.¹

Affiliation:

1. School of Pathology and Laboratory Medicine; University of Western Australia; Perth; WA; Australia

2. Amarillo Biosciences; Amarillo; TX; USA

3. Telethon Institute of Child Health Research; Perth; WA; Australia

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Reference39 articles.

1. World Health Organization Fact Sheet No 211:Seasonal Influenza 2009 http://www.who.int/mediacentre/factsheets/fs211/en/index.html

2. The annual impact of seasonal influenza in the US: measuring disease burden and costs;Molinari;Vaccine,2007

3. Meeting the challenge of influenza pandemic preparedness in developing countries;Fedson;Emerg Infect Dis,2009

4. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008;Fiore;MMWR Recomm Rep,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Review] Dr Jekyll and Mr Hyde: From Two Branches of Immune Response to Three Types of Interferon Response;2023-10-12

2. Antiviral Approaches against Influenza Virus;Clinical Microbiology Reviews;2023-03-23

3. Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond;Cells;2022-07-14

4. Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?;Viruses;2022-07-08

5. Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019;European Journal of Pharmacology;2022-07